May 6th, 2020   /   In the News

NorthStar construction, growth strong amid COVID-19

BELOIT — Company growth at NorthStar Medical Radioisotopes remains uninterrupted by COVID-19, according to CEO Steve Merrick.

Work continues at the headquarters on a new electron accelerator production building to expand capacity of the company’s non-uranium domestic supply of molybdenum-99 (Mo-99).  Read more…

Back to Newsroom


Do you have questions about NorthStar, our products, supply solutions, careers or anything else?

Contact Us Today